ID

26757

Beschreibung

Study Part: Adverse Events Week 5 PK Visit (Visit 9). An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Stichworte

  1. 23.10.17 23.10.17 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

23. Oktober 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Adverse Events Week 5 PK Visit (Visit 9) Ropinirole Parkinson Disease 101468/165

Adverse Events Week 5 PK Visit (Visit 9)

ADVERSE EVENTS +4.5 HOURS
Beschreibung

ADVERSE EVENTS +4.5 HOURS

Alias
UMLS CUI-1
C0877248
Patient Number
Beschreibung

Patient Number

Datentyp

text

Alias
UMLS CUI [1]
C1830427
Centre Number
Beschreibung

Centre Number

Datentyp

integer

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Visit Date
Beschreibung

Visit Date

Datentyp

date

Alias
UMLS CUI [1]
C1320303
Has the subject experienced any Adverse Events?
Beschreibung

Adverse Events

Datentyp

boolean

Alias
UMLS CUI [1]
C0877248
Has the subject taken any Concomitant medications?
Beschreibung

Concomitant medications

Datentyp

boolean

Alias
UMLS CUI [1]
C2347852
ADVERSE EVENTS +12.5 HOURS
Beschreibung

ADVERSE EVENTS +12.5 HOURS

Alias
UMLS CUI-1
C0877248
Has the subject experienced any Adverse Events?
Beschreibung

Adverse Events

Datentyp

boolean

Alias
UMLS CUI [1]
C0877248
Has the subject taken any Concomitant medications?
Beschreibung

Concomitant medications

Datentyp

boolean

Alias
UMLS CUI [1]
C2347852
ADVERSE EVENTS +24.5 HOURS
Beschreibung

ADVERSE EVENTS +24.5 HOURS

Alias
UMLS CUI-1
C0877248
Has the subject experienced any Adverse Events?
Beschreibung

Adverse Events

Datentyp

boolean

Alias
UMLS CUI [1]
C0877248
Has the subject taken any Concomitant medications?
Beschreibung

Concomitant medications

Datentyp

boolean

Alias
UMLS CUI [1]
C2347852

Ähnliche Modelle

Adverse Events Week 5 PK Visit (Visit 9)

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
ADVERSE EVENTS +4.5 HOURS
C0877248 (UMLS CUI-1)
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Centre Number
Item
Centre Number
integer
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Adverse Events
Item
Has the subject experienced any Adverse Events?
boolean
C0877248 (UMLS CUI [1])
Concomitant medications
Item
Has the subject taken any Concomitant medications?
boolean
C2347852 (UMLS CUI [1])
Item Group
ADVERSE EVENTS +12.5 HOURS
C0877248 (UMLS CUI-1)
Adverse Events
Item
Has the subject experienced any Adverse Events?
boolean
C0877248 (UMLS CUI [1])
Concomitant medications
Item
Has the subject taken any Concomitant medications?
boolean
C2347852 (UMLS CUI [1])
Item Group
ADVERSE EVENTS +24.5 HOURS
C0877248 (UMLS CUI-1)
Adverse Events
Item
Has the subject experienced any Adverse Events?
boolean
C0877248 (UMLS CUI [1])
Concomitant medications
Item
Has the subject taken any Concomitant medications?
boolean
C2347852 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video